Literature DB >> 17005829

Reactivity of (1-->3)-beta-d-glucan assay with commonly used intravenous antimicrobials.

Francisco M Marty1, Colleen M Lowry, Steven J Lempitski, David W Kubiak, Malcolm A Finkelman, Lindsey R Baden.   

Abstract

Forty-four intravenous antimicrobials were tested for the presence of (1-->3)-beta-d-glucan (BG). Colistin, ertapenem, cefazolin, trimethoprim-sulfamethoxazole, cefotaxime, cefepime, and ampicillin-sulbactam tested positive for BG at reconstituted-vial concentrations but not when diluted to usual maximum plasma concentrations. False-positive BG assays may occur when some antimicrobials are administered; however, this needs to be confirmed.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17005829      PMCID： PMC1610103          DOI： 10.1128/AAC.00658-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam.

Authors:  Annie Sulahian; Sophie Touratier; Patricia Ribaud
Journal:  N Engl J Med       Date:  2003-12-11       Impact factor: 91.245

2.  Galactomannan in piperacillin-tazobactam: how much and to what extent?

Authors:  Marco Machetti; Elisa Furfaro; Claudio Viscoli
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

Review 3.  Advances and challenges in management of invasive mycoses.

Authors:  Thomas F Patterson
Journal:  Lancet       Date:  2005 Sep 17-23       Impact factor: 79.321

4.  Clinical and experimental studies of the limulus test after digestive surgery.

Authors:  Y Kimura; A Nakao; H Tamura; S Tanaka; H Takagi
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

5.  Positive (1-->3)-beta-D-glucan in blood components and release of (1-->3)-beta-D-glucan from depth-type membrane filters for blood processing.

Authors:  Makoto Usami; Atsushi Ohata; Takeshi Horiuchi; Koichi Nagasawa; Toshio Wakabayashi; Shigenori Tanaka
Journal:  Transfusion       Date:  2002-09       Impact factor: 3.157

6.  Detection of Aspergillus galactomannan antigen in foods and antibiotics.

Authors:  R Ansorg; R van den Boom; P M Rath
Journal:  Mycoses       Date:  1997-12       Impact factor: 4.377

7.  Influence of various hemodialysis membranes on the plasma (1-->3)-beta-D-glucan level.

Authors:  H Kanda; K Kubo; K Hamasaki; Y Kanda; A Nakao; T Kitamura; T Fujita; K Yamamoto; T Mimura
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

8.  Differences in beta-glucan levels in culture supernatants of a variety of fungi.

Authors:  Zekaver Odabasi; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; Michael R McGinnis; Luis Ostrosky-Zeichner
Journal:  Med Mycol       Date:  2006-05       Impact factor: 4.076

9.  Experimental proof of contamination of blood components by (1-->3)-beta-D-glucan caused by filtration with cellulose filters in the manufacturing process.

Authors:  Koichi Nagasawa; Tatsuyuki Yano; Go Kitabayashi; Hiroaki Morimoto; Yuji Yamada; Atsushi Ohata; Makoto Usami; Takashi Horiuchi
Journal:  J Artif Organs       Date:  2003       Impact factor: 1.731

10.  False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam.

Authors:  Claudio Viscoli; Marco Machetti; Paola Cappellano; Barbara Bucci; Paolo Bruzzi; Maria Teresa Van Lint; Andrea Bacigalupo
Journal:  Clin Infect Dis       Date:  2004-02-27       Impact factor: 9.079
View more
  41 in total

1.  The Role of Biomarkers for Diagnosis of and Therapeutic Decisions Related to Invasive Aspergillosis in Children.

Authors:  Brian T Fisher
Journal:  Curr Fungal Infect Rep       Date:  2013-03-01

2.  How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors.

Authors:  H Hammarström; N Kondori; V Friman; C Wennerås
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-09       Impact factor: 3.267

3.  Invasive fungal infections in acute leukemia.

Authors:  Vijaya R Bhatt; George M Viola; Alessandra Ferrajoli
Journal:  Ther Adv Hematol       Date:  2011-08

4.  The Diagnostic Value of (1 → 3)-Beta-D-glucans and Galactomannan Assays in Children Suffering from Bacteremia in Pediatric Intensive Care Unit.

Authors:  Fang Zheng; Yelian Gu; Hui Zha; Jun Deng; Zhiquan Zhang
Journal:  Mycopathologia       Date:  2016-12-07       Impact factor: 2.574

5.  Diagnostic Values and Limitations of (1,3)-β-D-Glucans and Galactomannan Assays for Invasive Fungal Infection in Patients Admitted to Pediatric Intensive Care Unit.

Authors:  Fang Zheng; Hui Zha; Dandan Yang; Jun Deng; Zhiquan Zhang
Journal:  Mycopathologia       Date:  2016-09-23       Impact factor: 2.574

6.  Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.

Authors:  Florence Persat; Stéphane Ranque; Francis Derouin; Annie Michel-Nguyen; Stéphane Picot; Annie Sulahian
Journal:  J Clin Microbiol       Date:  2007-12-26       Impact factor: 5.948

7.  Clinical evaluation of a (1,3)-beta-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients.

Authors:  Valerio Del Bono; Alessandra Mularoni; Elisa Furfaro; Emanuele Delfino; Lorenzo Rosasco; Franca Miletich; Claudio Viscoli
Journal:  Clin Vaccine Immunol       Date:  2009-08-19

Review 8.  Diagnostic methods for invasive fungal diseases in patients with hematologic malignancies.

Authors:  Mary Mansour Riwes; John R Wingard
Journal:  Expert Rev Hematol       Date:  2012-12       Impact factor: 2.929

9.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

10.  Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.

Authors:  Annie Sulahian; Raphael Porcher; Anne Bergeron; Sophie Touratier; Emmanuel Raffoux; Jean Menotti; Francis Derouin; Patricia Ribaud
Journal:  J Clin Microbiol       Date:  2014-04-16       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.